Get in touch: 07730 619850
The Laser Trial will assess a new treatment device for
patients with allergic asthma - Professor Anoop Chauhan
allergen-avoidance

Allergen Avoidance

For patients with allergic asthma, the immune system’s abnormal reaction to allergens is a major cause of asthma symptoms.
Find out more

asthma-treatment

Asthma Treatment

TLA is a treatment for patients with allergic asthma who, despite taking their asthma medications, still have poorly controlled asthma.
Register your interest

tla-treatment

TLA Treatment

Treatment allows the patient to sleep in clean air. Studies show TLA treatment can improve quality of life and asthma control in patients with allergic asthma.
The Laser Trial

ongoing-support

Ongoing Support

We are dedicated to offer you the best service with support and updates you can rely on. Do not hesitate to contact us should you have any questions or require assistance.
Meet the team


logo-op-medium

The LASER trial will evaluate the effectiveness of a new treatment

It is hoped that the LASER Trial will demonstrate a reduction in the frequency of asthma attacks,
improving patients quality of life. A breath of fresh air in Asthma!

Can TLA reduce asthma attacks?

Asthma affects over 5 million people in the UK. Half a million of these have a severe form of the condition. Potentially life threatening attacks, known as exacerbations, are a frequent occurrence. Current treatment options to reduce the frequency of these exacerbations are limited.

Trial will include 222 adults

The LASER trial will evaluate the effectiveness of a new treatment – Temperature Controlled Laminar Airflow (TLA.) TLA is delivered by an Airsonett® machine. The machine is used overnight in the patient’s home at the bedside. The machine filters allergy particles from the air overnight, allowing patients to sleep and ‘rest’ their lungs.

A Breath of Fresh Air in Asthma!

Asthma affects over 5 million people in the UK. Half a million of these have a severe form of the condition. Potentially life threatening attacks, known as exacerbations, are a frequent occurrence. Current treatment options to reduce the frequency of these exacerbations are limited.
Unknown-2

Allergen Avoidance

For patients with allergic asthma, the immune system’s abnormal reaction to allergens is a major cause of asthma symptoms.

Unknown

Asthma Treatment

TLA is a treatment for patients with allergic asthma who, despite taking their asthma medications, still have poorly controlled asthma.

Unknown-1

TLA Treatment

Allows the patient to sleep in clean air. Studies show TLA treatment can improve quality of life and asthma control in patients with allergic asthma

Can patients quality of life be improved?

222 participants will be invited to take part in the trial. 111 will receive an active TLA device and 111 will receive a placebo device which has been de-activated. Participants will be seen over a 12 month period to assess their asthma control and quality of life. Asthma attacks during the 12 month period will be reported to the trial team to see if the active treatment device is more effective at reducing the frequency of these attacks when compared to the placebo device.  — Dr. Will Storrar

The LASER Trial - A breath of fresh air in Asthma!

The LASER Trial is funded by the National Institute for Health Research Health Technology Assessment Programme
(Project number 12/33/28)

Home March 22, 2014

Latest Tweets

Address

The LASER trial team
Dept. of Respiratory Medicine
Level C, Queen Alexandra Hospital
Southwick Hill Road
Cosham
Portsmouth, PO6 3LY
Website: http://lasertrial.co.uk
Email: info@lasertrial.co.uk

Get in touch

Contact the LASER Trial on 07730 619850, or by email info@lasertrial.co.uk

Keep up to date with what’'s happening at LASER trial by following us on Facebook and Twitter.